| G0378 | Hospital observation service, per hour | 26 | 80 | 6,290 | $690 | $6.6M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 38 | 130 | 3,180 | $60 | $4.2M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 70 | 260 | 4,240 | $220 | $4.1M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 38 | 320 | 580 | $230 | $4M |
| J2323 | Injection, natalizumab, 1 mg | 1 | 10 | 1,050 | $3,490 | $3M |
| J2350 | Injection, ocrelizumab, 1 mg | 1 | 10 | 130 | $14,830 | $2.8M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 55 | 280 | 920 | $200 | $2.6M |
| J9312 | Injection, rituximab, 10 mg | 4 | 10 | 180 | $5,830 | $2.2M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 82 | 150 | 3,680 | $30 | $1.5M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 28 | 40 | 1,690 | $70 | $1.4M |